相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Staurosporine allows dystrophin expression by skipping of nonsense-encoding exon
Atsushi Nishida et al.
BRAIN & DEVELOPMENT (2016)
Splice-switching antisense oligonucleotides as therapeutic drugs
Mallory A. Havens et al.
NUCLEIC ACIDS RESEARCH (2016)
CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
Michael Bidinosti et al.
SCIENCE (2016)
Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis
So Masaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Deciphering targeting rules of splicing modulator compounds: case of TG003
Maki Sakuma et al.
BMC MOLECULAR BIOLOGY (2015)
Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice
Gaelle Naert et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation
Brandon E. Aubol et al.
BIOCHEMICAL JOURNAL (2014)
Human CDC2-Like Kinase 1 (CLK1): A Novel Target for Alzheimer's Disease
Princi Jain et al.
CURRENT DRUG TARGETS (2014)
Genome-wide Analysis Reveals SR Protein Cooperation and Competition in Regulated Splicing
Shatakshi Pandit et al.
MOLECULAR CELL (2013)
Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree
Matthieu Chartier et al.
PEERJ (2013)
CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential
K. Shiomi et al.
GENE THERAPY (2011)
Stress-responsive maturation of Clk1/4 pre-mRNAs promotes phosphorylation of SR splicing factor
Kensuke Ninomiya et al.
JOURNAL OF CELL BIOLOGY (2011)
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
Atsushi Nishida et al.
NATURE COMMUNICATIONS (2011)
RNA-targeted splice-correction therapy for neuromuscular disease
Matthew J. A. Wood et al.
BRAIN (2010)
Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication
Alexander Karlas et al.
NATURE (2010)
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
Yasushi Ogawa et al.
NATURE COMMUNICATIONS (2010)
The SR protein family of splicing factors: master regulators of gene expression
Jennifer C. Long et al.
BIOCHEMICAL JOURNAL (2009)
Cooperative-Binding and Splicing-Repressive Properties of hnRNP A1
Hazeem L. Okunola et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Less is more: therapeutic exon skipping for Duchenne muscular dystrophy
Annemieke Aartsma-Rus et al.
LANCET NEUROLOGY (2009)
RNA-targeting approaches for neuromuscular diseases
Florence Le Roy et al.
TRENDS IN MOLECULAR MEDICINE (2009)
The SR protein family
Peter J. Shepard et al.
GENOME BIOLOGY (2009)
Combination of Clk family kinase and SRp75 modulates alternative splicing of Adenovirus E1A
Jun-ichiro Yomoda et al.
GENES TO CELLS (2008)
N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck:: Indazoles as phenol isosteres with improved pharmacokinetics
Paul Bamborough et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy
Y Takeshima et al.
PEDIATRIC RESEARCH (2006)
Manipulation of alternative splicing by a newly developed inhibitor of Clks
M Muraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation and substrate specificity of the SR protein kinase Clk/Sty
J Prasad et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins
J Zhu et al.
MOLECULAR CELL (2001)
分享论文
